Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Latest From DBV Technologies

US FDA Bids Adieu To Allergenic Products Adcomm; Vaccines Panel To Take Over Duties

The effort and expense to maintain the committee, which met only 10 days in the past 15 years, can no longer be justified, the FDA said. The terminated panel’s responsibilities will be integrated into the Vaccines and Related Biological Products Advisory Committee.

Advisory Committees Biologics

Novartis’s Peanut Allergy Setback Perks Up Rivals

Opportunity could knock for the smaller but more specialized players in the peanut allergy space now that Novartis has halted trials of its investigational IgE inhibitor ligelizumab.

Clinical Trials Immune Disorders

Stallergenes Greer Gets Hold Of Nestlé’s Palforzia For Peanuts

Nestlé has finally divested the peanut allergy business acquired in 2019 to much fanfare after the treatment spectacularly failed to live up to its blockbuster potential.

Deals Strategy

Nestlé Ponders Least Painful Exit From Peanut Allergy Misfire

Heralded as a potential blockbuster, Nestlé's acquisition of Palforzia has proved to be a very expensive mistake.

Business Strategies Launches
See All

Company Information

  • Industry
  • Medical Devices
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
      • Macromolecule
      • Transdermal
  • In Vitro Diagnostics
    • Chemistry, Immunoassay
  • Biotechnology
    • Large Molecule
    • Drug Discovery Tools
      • ADMET
UsernamePublicRestriction

Register